Accurate results
for patient care
Laboratory medicine and in vitro diagnostics
JCTLM Database: higher-order reference materials, methods and services
Details : C12RM1 - human serum
| Type (acronym) | rm2 |
|---|---|
| Type | reference material |
| Unique Nomination Number | C12RM1 |
| Analyte Name | anti-myeloperoxidase immunoglobulin G |
| IUPAC IFCC Number | anti-MPO IgG |
| List I, II or III | List I |
| Basis for Traceability Claim | Traceable to the stated value of the mass concentration in United States National Reference Preparation (USNRP) 12-0575C (Reimer et al., Am. J. Clin. Pathol., 1982, 77, 12-19) |
| Applicable Matrices | processed human serum |
| Identifier Number | ERM-DA476/IFCC |
| Name | human serum |
| Certifying Organization | IRMM |
| Quantity | Mass concentration |
| From (0) | 84.2 |
| To (0) | 84.2 |
| Unit (0) | mg/L |
| From (1) | 8.4 |
| To (1) | 8.4 |
| Unit (1) | mg/L |
| Level of Confidence (%) | 99 % |
| Reference to Commutability Study Publication | First steps in the standardization of immunoglobulin IgG myeloperoxidase-anti-neutrophil cytoplasmic antibody measurements, Hutu D P et al., Clin. Exp. Immunol., 2016, 183(2), 193-205 |
| Comments 1 | Each sample consists of at least 1 mL processed human serum spiked with anti-myeloperoxidase IgG. It contains the following additives: (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), sodium azide, bezamidine chloride and aprotinin). The material is kept under nitrogen gas in glass vials. |
| Recommended for Publication in the JCTLM List | yes |
| Organization Acronym | EU - JRC |
| Organization Name | European Commission - Joint Research Centre |
| Organization Website | https://crm.jrc.ec.europa.eu/ |
| Organization Country ISO Code | BE |
| Organization Country Name | Belgium |
| Analyte Category Name | Proteins |